Back
Karyopharm Therapeutics Vs. Bruker Industry Stock Comparison
Sell
28
KPTI
Karyopharm Therapeutics
Last Price:
0.85
Seasonality Move:
-2.8%
Sell
29
BRKR
Bruker
Last Price:
57.08
Seasonality Move:
6.72%
Sell
28
Karyopharm Therapeutics (KPTI)
is a Sell
Is Karyopharm Therapeutics a Buy, Sell or Hold?
- The current Karyopharm Therapeutics [KPTI] share price is $0.78. The Score for KPTI is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- KPTI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Bruker (BRKR)
is a Sell
Is Bruker a Buy, Sell or Hold?
- The current Bruker [BRKR] share price is $56.22. The Score for BRKR is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- BRKR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KPTI Stock Price Chart
What is Karyopharm Therapeutics's stock price today?
-
The Karyopharm Therapeutics share price today is $0.78
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KPTI is experiencing slight buying pressure.
BRKR Stock Price Chart
KPTI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 41.33 | Sell |
| Chaikin Money Flow: | -20521 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.81 - 0.91) | Sell |
| Bollinger Bands (100): | (0.76 - 0.92) | Sell |
BRKR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.58 | Sell |
| Relative Strength Index (14 RSI): | 47.74 | Sell |
| Chaikin Money Flow: | 2422265 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.71 - 60.79) | Sell |
| Bollinger Bands (100): | (58.62 - 67.02) | Sell |
KPTI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.82 | Sell |
| 20-day SMA: | 0.86 | Sell |
| 50-day SMA: | 0.82 | Sell |
| 200-day SMA: | 1.02 | Sell |
| 8-day EMA: | 0.81 | Sell |
| 20-day EMA: | 0.84 | Sell |
| 50-day EMA: | 0.84 | Sell |
| 200-day EMA: | 1.01 | Sell |
BRKR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.13 | Buy |
| 20-day SMA: | 56.42 | Sell |
| 50-day SMA: | 61.72 | Sell |
| 200-day SMA: | 71.01 | Sell |
| 8-day EMA: | 53.74 | Buy |
| 20-day EMA: | 56.14 | Buy |
| 50-day EMA: | 59.8 | Sell |
| 200-day EMA: | 66.42 | Sell |
Karyopharm Therapeutics Earnings Growth & KPTI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and a decrease next year of $0.01 per share.
Bruker Earnings Growth & BRKR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and an increase next year of $0.37 per share.
Karyopharm Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bruker Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||